Merck
CN
Search Within

141-28-6

Applied Filters:
Keyword:'141-28-6'
Showing 1-18 of 18 results for "141-28-6" within Papers
H Sprague Eustis et al.
Journal of pediatric ophthalmology and strabismus, 49(4), 206-209 (2012-08-23)
To document the contamination rate of sutures used in strabismus surgery and evaluate the reduction of contamination using antibiotic-coated and antiseptic/antibiotic-coated sutures. This was a prospective randomized analysis of suture contamination and potential prophylaxis measures after strabismus surgery. Muscle sutures
X Wang et al.
Journal of digital imaging, 21(2), 170-176 (2008-02-08)
HER-2/neu is a valuable therapeutic and prognostic marker in primary breast carcinomas. The aim of this study was to evaluate the association between mammographic calcifications and HER-2/neu overexpression in primary breast carcinomas and assess its clinical perspective. A retrospective study
P D Killen et al.
The Journal of biological chemistry, 263(18), 8706-8709 (1988-06-25)
Collagen IV, the major structural component of basement membranes, is composed of two genetically distinct polypeptide chains, alpha 1(IV) and alpha 2(IV). We have isolated a 522-base-pair (bp) cDNA to the 5' portion of the murine alpha 1(IV) chain mRNA
Maria S França-Silva et al.
Autonomic neuroscience : basic & clinical, 171(1-2), 28-35 (2012-11-13)
Previously, we found that the nitrate synthesized from glycerin, 2-nitrate-1,3-dibuthoxypropan (NDBP), increased NO levels in rat aortic smooth muscle cells, inducing vasorelaxation in mesenteric artery. However, its effects on blood pressure and heart rate as well as on autonomic function
G T Griffing et al.
Hypertension (Dallas, Tex. : 1979), 7(2), 178-181 (1985-03-01)
19-Nor-deoxycorticosterone (19-nor-DOC) is a human mineralocorticoid. The regulation of its secretion is poorly understood, as renin angiotensin II (ANG II) stimulation has minimal effects on 19-nor-DOC. This study sought to determine if ANG II inhibition would decrease 19-nor-DOC production. Six
Ulrich Arnold et al.
The FEBS journal, 279(14), 2508-2519 (2012-05-19)
Among the strategies that employ genetic engineering to stabilize proteins, the introduction of disulfide bonds has proven to be a very potential approach. As, however, the replacement of amino acid residues by cysteines and the subsequent formation of the covalent
Niikee C Schoendorfer et al.
European journal of clinical investigation, 42(7), 768-776 (2012-02-04)
Methylation cycle and folate-mediated one-carbon metabolism maintenance is important for many physiological processes including neurotransmitter regulation, nerve myelination and DNA synthesis. These processes play an indispensible role in growth and development, as well as in cognitive function and neuromuscular stability
Aya Miyazaki et al.
Heart and vessels, 30(1), 70-80 (2013-11-28)
Sudden cardiac arrest (SCA) is a major cause of death in patients with congenital heart disease (CHD). Systemic ventricular dysfunction is a reported risk factor for SCA. We retrospectively analyzed the medical records of 46 patients (age >6 years) who
Deborah K Fletcher et al.
European journal of applied physiology, 111(7), 1329-1339 (2010-12-15)
Several studies investigating the effect of caffeine on immune function following exercise have used one large bolus dose of caffeine. However, this does not model typical caffeine consumption. Therefore, the purpose of this study was to investigate whether small repeated
Bronwen E Shaw et al.
Blood, 107(3), 1220-1226 (2005-10-20)
Studies in unrelated donor (UD) hematopoietic stem cell transplantations (HSCT) show an effect of the matching status of HLA-DPB1 on complications. We analyzed 423 UD-HSCT pairs. Most protocols included T-cell depletion (TCD). All pairs had high-resolution tissue typing performed for
Vahid Asnafi et al.
Blood, 113(17), 3918-3924 (2008-12-26)
Many somatic genetic abnormalities have been identified in T-cell acute lymphoblastic leukemia (T-ALL) but each individual abnormality accounts for a small proportion of cases; therapeutic stratification consequently still relies on classical clinical markers. NOTCH1 and/or FBXW7 mutations both lead to
Matthew D Galsky et al.
Investigational new drugs, 30(2), 695-701 (2010-09-22)
To explore the activity of lapatinib with a novel trial design focused on the drug target rather than on histology. Patients with HER2 amplified gastro-esophageal, bladder, ovarian, or uterine tumors were enrolled into a double-blinded randomized discontinuation study of lapatinib
T A Grushko et al.
Gynecologic oncology, 108(1), 3-9 (2007-10-20)
To investigate the frequency and potential prognostic or predictive value of HER-2 amplification or overexpression in advanced and recurrent endometrial cancers. Immunohistochemical staining (IHC; DAKO Herceptest) and fluorescence in situ hybridization (FISH; Vysis Inc. PathVysion DNA Probe Kit) were performed
A Rodríguez de la Serna et al.
The Journal of rheumatology, 21(5), 927-933 (1994-05-01)
To assess in a multicenter double blind clinical trial the gastroenteroprotective effect of zinc acexamate (ZAC). 276 patients with rheumatic disease and history of peptic ulcer or intolerance to nonsteroidal antiinflammatory drugs (NSAID), and requiring treatment with these drugs were
Markus Riegersperger et al.
Transplantation, 95(11), 1338-1345 (2013-04-19)
Endothelial progenitor cell (EPC) counts are proposed surrogate markers for vascular function and cardiovascular risk. The effect of tacrolimus (TAC) on EPC is unknown. In this randomized controlled trial, we assigned 148 stable long-term kidney transplant recipients (KTR) to maintaining
Sean J Pittock et al.
Archives of neurology, 65(5), 629-632 (2008-05-14)
The neuromyelitis optica IgG autoantibody (NMO-IgG) is a validated biomarker for NMO and an emerging spectrum of inflammatory central nervous system-demyelinating disorders. Its antigen is the astrocytic water channel aquaporin-4; NMO-IgG has not been described in a cancer context. To
Lyndon F Cooper et al.
The International journal of oral & maxillofacial implants, 36(1), 165-176 (2021-02-19)
This study sought to define the tissue responses at different implant-abutment interfaces by studying bone and peri-implant mucosal changes using a 5-year prospective randomized clinical trial design study. The conus interface was compared with the flat-to-flat interface and platform-switched implant-abutment
Gunter von Minckwitz et al.
The Lancet. Oncology, 15(7), 747-756 (2014-05-06)
Preclinical data suggest that triple-negative breast cancers are sensitive to interstrand crosslinking agents, and that synergy may exist for the combination of a taxane, trastuzumab, and a platinum salt for HER2-positive breast cancer. We therefore aimed to assess the efficacy
Page 1 of 1